Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 7 articles:
HTML format
Text format



Single Articles


    July 2017
  1. LAMB YN, Duggan ST
    Ustekinumab: A Review in Moderate to Severe Crohn's Disease.
    Drugs. 2017;77:1105-1114.
    PubMed     Text format     Abstract available


    May 2017
  2. FLAMANT M, Rigaill J, Paul S, Roblin X, et al
    Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.
    Drugs. 2017 May 18. doi: 10.1007/s40265-017-0755.
    PubMed     Text format     Abstract available


    March 2017
  3. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Mar 1. doi: 10.1007/s40265-017-0719.
    PubMed     Text format    


    February 2017
  4. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Feb 23. doi: 10.1007/s40265-017-0693.
    PubMed     Text format     Abstract available


    January 2017
  5. BOAL CARVALHO P, Cotter J
    Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.
    Drugs. 2017 Jan 11. doi: 10.1007/s40265-016-0676.
    PubMed     Text format     Abstract available


    September 2016
  6. GECSE KB, Lakatos PL
    Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.
    Drugs. 2016.
    PubMed     Text format     Abstract available


    March 2014
  7. YAMAMOTO T
    Prevention of postoperative recurrence in Crohn's disease.
    Drugs. 2014;74:397-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: